- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03695497
Direct Anterior Approach for Femoral Neck Fractures
January 10, 2023 updated by: Helse Møre og Romsdal HF
A Randomized Controlled Trial Comparing Direct Anterior Approach to Direct Lateral Approach in Patients Receiving a Total Hip Arthroplasty for Femoral Neck Fracture - a 1 Year Follow-up Study
The primary objective is to examine if in patients with a dislocated femoral neck fracture who receive a total hip arthroplasty, direct anterior approach will give a better result in terms of mobilization, function and pain in the first weeks and months postoperatively, than direct lateral approach.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
first included patient 23th November 2018
Study Type
Interventional
Enrollment (Anticipated)
130
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: John Magne Hoseth, MD
- Phone Number: +47 71120000
- Email: john.magne.hoseth@helse-mr.no
Study Contact Backup
- Name: Otto Schnell Husby, md phd
Study Locations
-
-
-
Kristiansund, Norway
- Recruiting
- Kristiansund Hospital
-
Contact:
- John Magne Hoseth, MD
- Phone Number: +47 71120000
- Email: john.magne.hoseth@helse-mr.no
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Dislocated femoral neck fracture
Exclusion Criteria:
- Infection around the hip (soft tissue or bone)
- Pathologic fracture
- Excessive alcohol or substance abuse that most likely will give reduced compliance
- Patients with any fractures of the long bones in the lower extremity, fracture of the spine, and/or intra-thoracic or intra-abdominal injury (i.e., multiple trauma). Because the outcomes and clinical course of patients with multiple trauma may be quite different from a non-trauma patient.
- Bedridden patients/non-walkers
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Direct anterior approach
total hip arthroplasty with direct anterior approach
|
total hip arthroplasty with DAA
Other Names:
|
Experimental: Direct Lateral Approach
total hip arthroplasty with direct lateral approach
|
total hip arthroplasty with DLA
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Time Up and Go Test (TUG)
Time Frame: 2,6,12 weeks, and 1 year
|
2,6,12 weeks, and 1 year
|
|
Change in Forgotten Joint Score for hip (FJS-12)
Time Frame: 2,6,12 weeks, and 1 year
|
12 questions.
Every question is scored 1 (never) to 5 (mostly) according to the selected response categories.
Thus, the raw score ranges from 12 to 60.
The raw score is linearly transformed to a 0-100 scale and then reversed to obtain the final score.
Final score = 100 - ((sum(item01 to item12) - 12)/48*100) For the final 'Forgotten Joint Score -12' a high score indicates good outcome.
|
2,6,12 weeks, and 1 year
|
Change in Oxford Hip Score (OHS)
Time Frame: 2,6,12 weeks, and 1 year
|
12 questions.
Every question is scored 4 to 0 according to the selected response.
Thus it is a continuous score ranging from 48-0.
Each of the 12 questions on the Oxford hip score is scored in the same way with the score decreasing as the reported symptoms increase (ie.
become worse).
All questions are laid out similarly with response categories denoting least (or no) symptoms being to the left of the page (scoring 4) and those representing greatest severity lying on the right hand side (scoring 0).
|
2,6,12 weeks, and 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in EQ-5D-5L score
Time Frame: 2,6,12 weeks, and 1 year
|
5 questions.
Every question is scored 1 to 5 where 5 is worse outcome.
For example one profile could be' 12233' We then convert this specific health state to an index value specific for that country.
The index value calculator can be downloaded from the EuroQol Office
|
2,6,12 weeks, and 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Øystein B Lian, md phd, Helse Møre og Romsdal Hospital Trust (HF), Kristiansund Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2018
Primary Completion (Anticipated)
October 1, 2024
Study Completion (Anticipated)
October 1, 2024
Study Registration Dates
First Submitted
October 2, 2018
First Submitted That Met QC Criteria
October 3, 2018
First Posted (Actual)
October 4, 2018
Study Record Updates
Last Update Posted (Actual)
January 12, 2023
Last Update Submitted That Met QC Criteria
January 10, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018/935
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Femoral Neck Fractures
-
Sundsvall HospitalCompletedFemoral Neck FractureSweden
-
Hospices Civils de LyonCompleted
-
RenJi HospitalRecruiting
-
Sorlandet Hospital HFCompleted
-
Hartford HospitalZimmer BiometCompletedFemoral Neck FractureUnited States
-
First Hospitals affiliated to the China PLA General...Unknown
-
Danderyd HospitalCompletedFemoral Neck FractureSweden
-
Istanbul UniversityCompletedFemoral Neck Fractures | Femoral Neck ShorteningTurkey
-
Hebei Medical University Third HospitalUnknown
-
University Hospital, AngersCompletedFemoral Neck FractureFrance
Clinical Trials on Direct Lateral Approach
-
Iuliu Hatieganu University of Medicine and PharmacyEmergency County Hospital Cluj-NapocaCompleted
-
National and Kapodistrian University of AthensUnknownHip Fractures | Femoral Neck Fractures
-
Sorlandet Hospital HFUnknown
-
Sykehuset Innlandet HFRecruitingHip FracturesNorway
-
University of Sao Paulo General HospitalUniversity of Campinas, BrazilUnknown
-
Sahlgrenska University Hospital, SwedenVastra Gotaland RegionRecruitingMuscle Weakness | Muscle Atrophy | Hip Osteoarthritis | Arthroplasty Complications | Muscle InjurySweden
-
Seoul National University Bundang HospitalCompletedArthroplasty, Replacement, HipKorea, Republic of
-
Zonguldak Bulent Ecevit UniversityCompletedUpper Extremity Fracture | Regional Anesthesia | Brachial Plexus Blocks | Perfusion Index | Tissue PerfusionTurkey
-
Istanbul UniversitySisli Hamidiye Etfal Training and Research HospitalCompletedRecurrent Laryngeal Nerve InjuriesTurkey